Hartung T - Search Results

1

The Center for Alternatives to Animal Testing - Europe (CAAT-EU): a transatlantic bridge for the paradigm shift in toxicology.

Daneshian M, Leist M, Hartung T. Daneshian M, et al. Among authors: hartung t. ALTEX. 2010;27(1):63-9. doi: 10.14573/altex.2010.1.63. ALTEX. 2010. PMID: 20390240 Free article.

2

Granulocyte colony-stimulating factor treatment protects rodents against lipopolysaccharide-induced toxicity via suppression of systemic tumor necrosis factor-alpha.

Görgen I, Hartung T, Leist M, Niehörster M, Tiegs G, Uhlig S, Weitzel F, Wendel A. Görgen I, et al. Among authors: hartung t. J Immunol. 1992 Aug 1;149(3):918-24. J Immunol. 1992. PMID: 1378868

3

[Hip, hip, hurrah! Americans celebrate Gen-Chip--are we celebrating too?].

Hartung T. Hartung T. ALTEX. 2000;17(2):101-2. ALTEX. 2000. PMID: 11085863 German. No abstract available.

4

Is replacement of animal experimentation in pharmacology a goal or a social constraint, utopia or reality?

Hartung T, Wendel A. Hartung T, et al. ALTEX. 1998;15(4):213-215. ALTEX. 1998. PMID: 11178520 English.

5

[Good cell culture practice (GCCP)--an initiative for standardization and quality control of in vitro studies. The establishment of an ECVAM Task Force on GCCP].

Hartung T, Gstraunthaler G, Coecke S, Lewis D, Blanck O, Balls M. Hartung T, et al. ALTEX. 2001;18(1):75-8. ALTEX. 2001. PMID: 11248855 German.

6

Three Rs potential in the development and quality control of pharmaceuticals.

Hartung T. Hartung T. ALTEX. 2001;18 Suppl 1:3-13. ALTEX. 2001. PMID: 11854852

7

Mitogen-activated protein kinase-activated protein kinase 2-deficient mice show increased susceptibility to Listeria monocytogenes infection.

Lehner MD, Schwoebel F, Kotlyarov A, Leist M, Gaestel M, Hartung T. Lehner MD, et al. Among authors: hartung t. J Immunol. 2002 May 1;168(9):4667-73. doi: 10.4049/jimmunol.168.9.4667. J Immunol. 2002. PMID: 11971016

8

Inhibition of microglial inflammation by the MLK inhibitor CEP-1347.

Lund S, Porzgen P, Mortensen AL, Hasseldam H, Bozyczko-Coyne D, Morath S, Hartung T, Bianchi M, Ghezzi P, Bsibsi M, Dijkstra S, Leist M. Lund S, et al. Among authors: hartung t. J Neurochem. 2005 Mar;92(6):1439-51. doi: 10.1111/j.1471-4159.2005.03014.x. J Neurochem. 2005. PMID: 15748162 Free article.

9

A new method to measure air-borne pyrogens based on human whole blood cytokine response.

Kindinger I, Daneshian M, Baur H, Gabrio T, Hofmann A, Fennrich S, von Aulock S, Hartung T. Kindinger I, et al. Among authors: hartung t. J Immunol Methods. 2005 Mar;298(1-2):143-53. doi: 10.1016/j.jim.2005.01.006. J Immunol Methods. 2005. PMID: 15847804

10

In vitro pyrogen test for toxic or immunomodulatory drugs.

Daneshian M, Guenther A, Wendel A, Hartung T, von Aulock S. Daneshian M, et al. Among authors: hartung t. J Immunol Methods. 2006 Jun 30;313(1-2):169-75. doi: 10.1016/j.jim.2006.04.009. Epub 2006 May 19. J Immunol Methods. 2006. PMID: 16730742

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

659 results

Search Page

Filters